| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | S-1 | S-1 |
| Revenues | 0.0 | 1.7 | 3.0 |
| Revenue growth | -100.0% | -41.8% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 1.7 | 3.0 |
| Gross margin | | 100.0% | 100.0% |
| Selling, general and administrative [+] | 13.1 | 11.2 | 8.7 |
| General and administrative | 13.1 | 11.2 | 8.7 |
| Research and development | | 42.9 | 23.5 |
| EBITDA [+] | | -50.5 | -28.5 |
| EBITDA growth | -74.1% | 77.2% | |
| EBITDA margin | | -2892.4% | -950.1% |
| Depreciation and amortization | | 1.8 | 0.7 |
| EBIT [+] | -13.1 | -52.3 | -29.2 |
| EBIT growth | -75.0% | 79.0% | |
| EBIT margin | | -2992.8% | -973.1% |
| Interest expense, net [+] | 0.0 | 0.9 | -0.5 |
| Interest expense | | 1.0 | 0.3 |
| Interest income | 0.0 | 0.1 | 0.9 |
| Other income (expense), net [+] | -2.0 | 0.0 | 0.0 |
| Gain (loss) on derivative instruments | -1.3 | | |
| Unrealized gain/loss on derivatives | -0.7 | 0.0 | 0.0 |
| Other | -2.0 | -1.0 | 0.6 |
| Pre-tax income | -15.1 | -53.3 | -28.6 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -15.1 | -53.3 | -37.2 |
| Net margin | | -3048.1% | -1238.1% |
| |
| Basic EPS [+] | | ($0.69) | ($10.81) |
| Growth | | -93.7% | |
| Diluted EPS [+] | | ($0.69) | ($10.81) |
| Growth | | -93.7% | |
| |
| Shares outstanding (basic) [+] | | 77.7 | 3.4 |
| Growth | | 2159.7% | |
| Shares outstanding (diluted) [+] | | 77.7 | 3.4 |
| Growth | | 2159.7% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |